High Protein Kinase B (Akt) Concentration in Attention Deficit Hyperactivity Disorder: Short Communication

Russo AJ

doi:10.58372/2835-6276.1176

Authors

Russo AJ

DOI:

https://doi.org/10.58372/2835-6276.1176

Abstract

Attention-deficit hyperactivity disorder (ADHD) is characterized by inattentiveness, hyperactivity, and impulsivity. It has been suggested that the mTOR pathway, which downstream includes activation of Akt, is involved in ADHD. In this study we measured the concentration of phosphorylated Akt in 55 ADD patients and 32 neurotypical controls using an ELISA. We found that Akt levels were significantly higher in the ADD group and may be important to the etiology of ADD/ADHD.

References

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (APA, 2013).

Antshel KM, Zhang-James Y, Wagner KE, Ledesma A, Faraone SV. An update on the comorbidity of ADHD and ASD: a focus on clinical management. Expert Rev. Neurother. 2016;16:279–293.

Yde Ohki CM, Grossmann L, Alber E, Dwivedi T, Berger G, Werling AM, Walitza S, Grünblatt E. The stress-Wnt-signaling axis: a hypothesis for attention-deficit hyperactivity disorder and therapy approaches. Transl Psychiatry. 2020 Sep 18;10(1):315.

Okano, L., Ji, Y., Riley, A. W. & Wang, X. Maternal psychosocial stress and children’s ADHD diagnosis: a prospective birth cohort study. J. Psychosom. Obstetr. Gynecol.10.1080/0167482X.2018.1468434 (2018).

Alexander N, et al. Impact of antenatal synthetic glucocorticoid exposure on endocrine stress reactivity in term-born children. J. Clin. Endocrinol. Metab. 2012;97:3538–3544.

Odaka H, Adachi N, Numakawa T. Impact of glucocorticoid on neurogenesis. Neural Regen. Res. 2017;12:1028–1035.

Ryskalin, L., Limanaqi, F., Frati, A., Busceti, C. L. & Fornai, F. mTOR-related brain dysfunctions in neuropsychiatric disorders. Int. J. Mol. Sci. 19, 10.3390/ijms19082226 (2018).

Sawicka K, Zukin RS. Dysregulation of mTOR signaling in neuropsychiatric disorders: therapeutic implications. Neuropsychopharmacology. 2012;37:305–306.

Russo A, Mensah A, Bowman J.. Decreased Phosphorylated CREB and AKT in Individuals with Autism Normalized after Zinc Therapy. Acad J Ped Neonatol. 2017; 5(4): 555721.

Russo AJ. Decreased Phosphorylated Protein Kinase B (Akt) in Individuals with Autism Associated with High Epidermal Growth Factor Receptor (EGFR) and Low Gamma-Aminobutyric Acid (GABA). Biomark Insights. 2015 Oct 14;10:89-94.

Suzuki K, Hashimoto K, Iwata Y, Nakamura K, Tsujii M, Tsuchiya KJ, et al. Decreased serum levels of epidermal growth factor in adult subjects with high-functioning autism. Biol Psychiatry(2007) 62(3):267–9.

Russo AJ. Decreased epidermal growth factor (EGF) associated with HMGB1 and increased hyperactivity in children with autism. Biomark Insights (2013) 8:35–41.

Russo AJ. Decreased phosphorylated protein kinase B (Akt) in individuals with autism associated with high epidermal growth factor receptor (EGFR) and low gamma-aminobutyric acid (GABA). Biomark Insights (2015) 10:89–94.

Yang E-J, Ahn S, Lee K, Mahmood U, Kim H-S. Early behavioral abnormalities and perinatal alterations of PTEN/AKT pathway in valproic acid autism model mice. PLoS One (2016) 11(4):e0153298.